PRKDC and osteosarcoma: To examine the impact of DNA‐PKcs on the reaction of osteosarcoma cells to anlotinib in vivo, xenograft tumour models were formulated among nude mice through MG63 cells steadily transfected using either PRKDC shRNA or a control shRNA lentivirus.